VSMC–NFATc3 overexpression aggravated AAA, with increased mortality rate, higher incidence, larger abdominal aorta maximal diameter, increased elastin degradation, and decreased collagen content (Fig. 3I–K, Fig. S4B–S4F). The gene discussed is NFATC3; the disease is triple-A syndrome.